Status:
COMPLETED
To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed Conditions
Lead Sponsor:
Sandoz
Conditions:
Infection
Eligibility:
All Genders
19-55 years
Phase:
PHASE1
Brief Summary
To demonstrate the bioequivalence of Azithromycin 600 mg Tablets Under Fed Conditions.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening
Exclusion
- Positive test results for HIV or hepatitis B or C
- Treatment for drug or alcohol dependence
- Female subjects who are pregnant or lactating
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2003
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT00865670
Start Date
August 1 2003
End Date
September 1 2003
Last Update
March 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.